Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2018 / Aug / Diagnostic Confidence: It’s in the DNA
Retina

Diagnostic Confidence: It’s in the DNA

Enhance your clinical decision making with the SPECTRALIS® imaging platform for retina and glaucoma. The true potential of multimodal diagnostic imaging awaits you.

8/1/2018 1 min read

Share

No matter how you configure your SPECTRALIS, you can be sure it contains the core DNA for high contrast, high resolution images that cut through the noise and give you the confidence to pinpoint pathology, identify real change and make more informed clinical decisions. SPECTRALIS offers an upgradeable, multimodal platform with confocal fundus imaging, TruTrack Active Eye Tracking, retinal recognition, noise reduction and 10 layer visualization. These features form the core of the SPECTRALIS DNA for diagnostic confidence. As new technology becomes available, it is simple to add new imaging modalities to the SPECTRALIS, providing additional information to enhance clinical decision-making, while preserving patient data for follow-up.

Multimodel Imaging

SPECTRALIS modular options include:

  • Glaucoma Module Premium Edition
  • MultiColor Module
  • BluePeak Module
  • Anterior Segment Module
  • OCT2 Module
  • OCT Angiography Module
  • Scanning Laser Angiography
  • Widefield Imaging Module
  • Ultra-Widefield Imaging Module

Confocal scanning laser ophthalmoscopy (cSLO) provides high contrast, high quality images, even in challenging patients with media opacities. Live fundus assessment with simultaneously-captured OCT enables you to identify and capture pathology in real time, providing complementary diagnostic information. The SPECTRALIS averages up to 100 B-scans in the same location to remove noise and provide high resolution OCT images for visualization of 10 retinal layers, to help you pinpoint and assess pathology. TruTrack Active Eye Tracking is patented technology that uses a second laser beam to actively track the eye during OCT scanning to avoid motion artifacts. It effectively “freezes” the retina, allowing you to capture the precise OCT image you want, even if the patient blinks or moves. The retinal recognition technology automatically repositions the OCT scan in the same anatomic location at follow-up for incredible accuracy. Detect changes as small as 1 micron and confidently monitor disease progression over time. To learn more about the DNA of SPECTRALIS visit www.spectralis-oct.com. *The SPECTRALIS OCT Angiography Module has not been cleared by the FDA for use in the United States.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: